Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Stolte, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ciarimboli, G; Bokenkamp, A; Schurek, HJ; Fels, LM; Kilian, I; Maess, B; Stolte, H
      The "fixed" charge of glomerular capillary wall as determinant of permselectivity

      RENAL FAILURE
    2. Hartmann, JT; von Vangerow, A; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

      BRITISH JOURNAL OF CANCER
    3. Hartmann, JT; Knop, S; Fels, LM; van Vangerow, A; Stolte, H; Kanz, L; Bokemeyer, C
      The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

      ANTI-CANCER DRUGS
    4. Hartmann, JT; Fels, LM; Franzke, A; Knop, S; Renn, M; Maess, B; Panagiotou, P; Lampe, H; Kanz, L; Stolte, H; Bokemeyer, C
      Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide

      ANTICANCER RESEARCH
    5. Hartmann, JT; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors

      INVESTIGATIONAL NEW DRUGS
    6. Price, RG; Wedeen, R; Lichtveld, MY; Lybarger, JA; Porter, GA; Fels, L; Stolte, H; Safirstein, RL; Mueller, PW; Manley, S; Whiting, PH; Gomez, RA; Finn, WF
      Urinary biomarkers: Roles in risk assessment to environmental and occupational nephrotoxins: Monitoring of effects and evaluation of mechanisms of toxicity

      RENAL FAILURE
    7. Ciarimboli, G; Schurek, HJ; Zeh, M; Flohr, H; Bokenkamp, A; Fels, LM; Kilian, I; Stolte, H
      Role of albumin and glomerular capillary wall charge distribution on glomerular permselectivity: studies on the perfused-fixed rat kidney model

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    8. FELS LM; WUNSCH M; BARANOWSKI J; NORSKABOROWKA I; PRICE RG; TAYLOR SA; PATEL S; DEBROE M; ELSEVIER MM; LAUWERYS R; ROELS H; BERNARD A; MUTTI A; GELPI E; ROSELLO J; STOLTE H
      ADVERSE-EFFECTS OF CHRONIC LOW-LEVEL LEAD-EXPOSURE ON KIDNEY-FUNCTION- A RISK GROUP-STUDY IN CHILDREN

      Nephrology, dialysis, transplantation
    9. KLANKE B; SIMON M; ROCKL W; WEICH HA; STOLTE H; GRONE HJ
      EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) VASCULAR-PERMEABILITY FACTOR (VPF) ON HEMODYNAMICS AND PERMSELECTIVITY OF THE ISOLATED-PERFUSED RAT-KIDNEY

      Nephrology, dialysis, transplantation
    10. BOKENKAMP A; CIARIMBOLI G; KILIAN I; KLANKE B; SCHUREK HJ; STOLTE H
      DETERMINATION OF THE GLOMERULAR SIEVING COEFFICIENT IN THE ISOLATED RAT-KIDNEY AFTER FIXATION WITH GLUTARALDEHYDE

      Journal of the American Society of Nephrology
    11. BOKEMEYER C; HARTMANN JT; FELS L; KNOP S; STOLTE H; KANZ L
      AMIFOSTINE PROTECTS AGAINST ACUTE CISPLATIN IFOSFAMIDE-INDUCED KIDNEYDAMAGE ASSESSED BY MEASUREMENT OF GLOMERULAR AND TUBULAR ENZYMES/

      European journal of cancer
    12. MUELLER PW; LASH LH; PRICE RG; STOLTE H; GELPI E; MAACK T; BERNDT WO
      URINARY BIOMARKERS TO DETECT SIGNIFICANT EFFECTS OF ENVIRONMENTAL ANDOCCUPATIONAL EXPOSURE TO NEPHROTOXINS .1. CATEGORIES OF TESTS FOR DETECTING EFFECTS OF NEPHROTOXINS

      Renal failure
    13. BERNARD A; STOLTE H; DEBROE ME; MUELLER PW; MASON H; LASH LH; FOWLER BA
      URINARY BIOMARKERS TO DETECT SIGNIFICANT EFFECTS OF ENVIRONMENTAL ANDOCCUPATIONAL EXPOSURE TO NEPHROTOXINS .4. CURRENT INFORMATION ON INTERPRETING THE HEALTH IMPLICATIONS OF TESTS

      Renal failure
    14. TAYLOR SA; CHIVERS ID; PRICE RG; ARCETOMAS M; MILLIGAN P; FRANCINI I; ALINOVI R; CAVAZZINI S; BERGAMASCHI E; VITTORI M; MUTTI A; LAUWERYS RR; BERNARD AM; ROELS HA; DEBROE ME; NUYTS GD; ELSEVIERS MM; HOTTER G; RAMIS I; ROSELLO J; GELPI E; STOLTE H; EISENBERGER U; FELS LM
      THE ASSESSMENT OF BIOMARKERS TO DETECT NEPHROTOXICITY USING AN INTEGRATED DATABASE

      Environmental research
    15. PRICE RG; TAYLOR SA; CHIVERS I; ARCETOMAS M; CRUTCHER E; FRANCHINI I; ALINOVI R; CAVAZZINI S; BERGAMASCHI E; MUTTI A; VETTORI MV; LAUWERYS R; BERNARD A; KABANDA A; ROELS H; THIELEMANS N; HOTZ P; DEBROE M; ELSEVIERS MM; NUYTS GD; GELPI E; HOTTER G; RASELLO J; RAMIS I; STOLTE H; FELS LM; EISENBERGER U
      DEVELOPMENT AND VALIDATION OF NEW SCREENING-TESTS FOR NEPHROTOXIC EFFECTS

      Human & experimental toxicology
    16. JONAS E; JACKLEMEYER I; SZUKICS B; STOLTE H
      URINARY FIBRONECTIN EXCRETION IN STREPTOZOTOCIN-DIABETIC RATS

      European journal of clinical chemistry and clinical biochemistry
    17. GAEDEKE J; FELS LM; BOKEMEYER C; MENGS U; STOLTE H; LENTZEN H
      CISPLATIN NEPHROTOXICITY AND PROTECTION BY SILIBININ

      Nephrology, dialysis, transplantation
    18. FELS LM; BOKEMEYER C; VANRHEE J; SCHMOLL HJ; STOLTE H
      EVALUATION OF LATE NEPHROTOXICITY IN LONG-TERM SURVIVORS OF HODGKINS-DISEASE

      Oncology
    19. WENZEL S; STOLTE H; SOOSE M
      EFFECTS OF SILIBININ AND ANTIOXIDANTS ON HIGH GLUCOSE-INDUCED ALTERATIONS OF FIBRONECTIN TURNOVER IN HUMAN MESANGIAL CELL-CULTURES

      The Journal of pharmacology and experimental therapeutics
    20. BOJKO JB; BURLAGE M; ERDAG S; NUSTEDE R; STOLTE H; FOLSCH UR; SCHMIDT WE
      NOVEL GRP CCK TEST EVALUATES ANTRAL D-G CELL-INTERACTION AND PARIETAL-CELL SECRETION IN HP-POSITIVE DUODENAL-ULCER PATIENTS/

      Gastroenterology
    21. SCHAFER H; BOJKO JB; NEUMANN P; STOLTE H; FOLSCH UR; SCHMIDT WE
      MOLECULAR AND CELLULAR MECHANISMS OF HYPERGASTRINEMIA AND HYPERSECRETION OF ACID IN PATIENTS INFECTED WITH HELICOBACTER-PYLORI

      Gastroenterology
    22. SCHMIDT WE; BOJKO JB; BURLAGE M; SCHAFER H; FOLSCH UR; NUSTEDE R; STOLTE H
      FUNDIC SOMATOSTATIN-MEDIATED INHIBITION OF GASTRIN-STIMULATED ACID-SECRETION IS DEFECTIVE IN HELICOBACTER-PYLORI GASTRITIS

      Gastroenterology
    23. BOKEMEYER C; FELS LM; DUNN T; VOIGT W; GAEDEKE J; SCHMOLL HJ; STOLTE H; LENTZEN H
      SILIBININ PROTECTS AGAINST CISPLATIN-INDUCED NEPHROTOXICITY WITHOUT COMPROMISING CISPLATIN OR IFOSFAMIDE ANTITUMOR-ACTIVITY

      British Journal of Cancer
    24. KASTNER S; FELS LM; KOOBEMUNDS L; PIIPPO S; STOLTE H
      EFFECTS OF ADRIAMYCIN ON THE BALANCE OF GLOMERULAR PROTEIN-METABOLISM- STUDIES IN ISOLATED GLOMERULI OF THE ATLANTIC HAGFISH, MYXINE GLUTINOSA

      Cellular physiology and biochemistry
    25. EISENBERGER U; FELS LM; OLBRICHT CJ; STOLTE H
      CATHEPSIN-B AND CATHEPSIN-L IN ISOLATED PROXIMAL TUBULAR SEGMENTS DURING ACUTE AND CHRONIC PROTEINURIA

      Renal physiology and biochemistry
    26. JACKLEMEYER I; SZUKICS B; NEUBAUER K; METZE V; PETZOLDT R; STOLTE H
      EXTRACELLULAR-MATRIX PROTEINS AS EARLY MARKERS IN DIABETIC NEPHROPATHY

      European journal of clinical chemistry and clinical biochemistry
    27. SOOSE M; WENZEL S; PADUR A; OBERST D; STOLTE H
      FIBRONECTIN EXPRESSION IN HUMAN MESANGIAL CELL-CULTURES AND ITS ALTERATIONS BY ADRIAMYCIN

      Cell biology and toxicology
    28. HOTTER G; FELS LM; CLOSA D; ROSELLO J; STOLTE H; GELPI E
      ALTERED LEVELS OF URINARY PROSTANOIDS IN LEAD-EXPOSED WORKERS

      Toxicology letters
    29. FELS LM; EISENBERGER U; HERBORT C; JUNG K; PERGANDE M; STOLTE H
      EARLY URINARY DETECTION OF RENAL DYSFUNCTION FOLLOWING HEAVY-METAL EXPOSURE - CLINICAL ROUTINE APPLICATION

      Kidney international
    30. FELS LM; GAEDEKE J; STOCKMANN S; BOKEMEYER C; DUNN T; SCHMOLL HJ; STOLTE H
      PROTECTION OF CYTOSTATIC INDUCED NEPHROTOXICITY BY SILIBININ AND SUPEROXIDE-DISMUTASE (SOD)

      Kidney international
    31. KLANKE B; GRONE HJ; GROS H; SIMON M; STOLTE H; WEICH HA
      EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ON HEMODYNAMICS AND PERMSELECTIVITY OF THE ISOLATED-PERFUSED RAT-KIDNEY (IPRK)

      Kidney international
    32. EISENBERGER U; KASTNER S; LUBBE K; SCHLENKE P; RELLER B; FELS LM; STOLTE H
      GLOMERULAR PROTEOLYSIS AND PROTEIN-SYNTHESIS IN GLOMERULOSCLEROSIS OFMILAN NORMOTENSIVE RATS

      Kidney international
    33. SOOSE M; WENZEL S; HOKAMP L; STOLTE H
      CYTOPROTECTION BY SILIBININ AGAINST CHANGES OF FIBRONECTIN TURNOVER INDUCED BY ADRIAMYCIN AND HIGH GLUCOSE IN HUMAN MESANGIAL CELL-CULTURES

      Kidney international
    34. KASTNER S; LUBBE K; FELS LM; STOLTE H
      GLOMERULAR HYPERPLASIA AND HYPERTROPHY IN MILAN NORMOTENSIVE STRAIN RATS EX-VIVO STUDIES IN ISOLATED GLOMERULI

      Kidney international
    35. KASTNER S; FELS LM; PIIPPO S; STOLTE H
      ISOLATED GLOMERULI OF THE ATLANTIC HAGFISH MYXINE GLUTINOSA AS AN ALTERNATIVE IN-VITRO MODEL TO STUDY GLOMERULAR PROTEIN-METABOLISM IN PHARMACOTOXICOLOGY OF ANTICANCER DRUGS

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    36. KLANKE B; GRONE HJ; GROS H; SIMON M; STOLTE H; WEICH HA
      EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ON HEMODYNAMICS AND PERMSELECTIVITY OF THE ISOLATED-PERFUSED RAT-KIDNEY (IPRK)

      Journal of the American Society of Nephrology
    37. SOOSE M; ZULAUF J; BAUER M; STOLTE H
      A COMPARATIVE-STUDY ON THE RESPONSE OF 2 ESTABLISHED CELL-LINES TO ADRIAMYCIN - GROWTH AND BIOMASS PRODUCTION IN HUMAN MESANGIAL CELL-CULTURES AND IN TETRAHYMENA-THERMOPHILA

      European journal of protistology
    38. PERGANDE M; JUNG K; PRECHT S; FELS LM; HERBORT C; STOLTE H
      CHANGED EXCRETION OF URINARY PROTEINS AND ENZYMES BY CHRONIC EXPOSURETO LEAD

      Nephrology, dialysis, transplantation
    39. FELS LM; HERBORT C; PERGANDE M; JUNG K; HOTTER G; ROSELLO J; GELPI E; MUTTI A; DEBROE M; STOLTE H
      NEPHRON TARGET SITES IN CHRONIC EXPOSURE TO LEAD

      Nephrology, dialysis, transplantation
    40. FELS LM; BUNDSCHUH I; GWINNER W; JUNG K; PERGANDE M; GRAUBAUM HJ; PRICE RG; TAYLOR SA; DEBROE ME; NUYTS GD; MUTTI A; FRANCHINI I; LAUWERYS R; ROELS H; BERNARD A; GELPI E; ROSELLO J; HOTTER G; STOLTE H
      EARLY URINARY MARKERS OF TARGET NEPHRON SEGMENTS AS STUDIED IN CADMIUM TOXICITY

      Kidney international
    41. FELS LM; SANZALTAMIRA PM; DECKER B; ELGER B; STOLTE H
      FILTRATION CHARACTERISTICS OF THE SINGLE ISOLATED-PERFUSED GLOMERULUSOF MYXINE-GLUTINOSA

      Renal physiology and biochemistry
    42. SOOSE M; WENZEL S; STOLTE H
      FIBRONECTIN TURNOVER IN HUMAN MESANGIAL CELL-CULTURES AS AFFECTED BY ADRIAMYCIN

      Cell biology and toxicology
    43. FELS LM; JUNG K; PERGANDE M; STOLTE H
      TARGET SELECTIVITY WITHIN THE SINGLE NEPHRON AND EARLY MARKERS OF RENAL DYSFUNCTION FOLLOWING CADMIUM EXPOSURE

      Kidney international
    44. GWINNER W; JACKLEMEYER I; STOLTE H
      ORIGIN OF URINARY FIBRONECTIN

      Laboratory investigation
    45. JUNG K; PERGANDE M; GRAUBAUM HJ; FELS LM; ENDL U; STOLTE H
      URINARY PROTEINS AND ENZYMES AS EARLY INDICATORS OF RENAL DYSFUNCTIONIN CHRONIC EXPOSURE TO CADMIUM

      Clinical chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/11/20 alle ore 13:46:39